Similar articles

• Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions - part II.

  Nunning BC, Granatek AP. Nunning BC, et al. Curr Ther Res Clin Exp. 1976 Oct;20(4):359-68. Curr Ther Res Clin Exp. 1976. PMID: 12917 No abstract available.
• Physical compatibility and chemical stability of amikacin sulfate in combination with non-antibiotic drugs in large-volume parenteral solutions - part IV.

  Nunning BC, Granatek AP. Nunning BC, et al. Curr Ther Res Clin Exp. 1976 Oct;20(4):417-91. Curr Ther Res Clin Exp. 1976. PMID: 12918 No abstract available.
• Pharmaceutics of cephapirin sodium (Cefadyl) a new semisynthetic cephalosporin - part III.

  Prasad VK, Johns WH, Wingate MW, Mihotic MM, Southard BJ, Kaplan MA, Granatek AP. Prasad VK, et al. Curr Ther Res Clin Exp. 1974 Nov;16(11):1214-37. Curr Ther Res Clin Exp. 1974. PMID: 4214656 No abstract available.
• [Antibacterial stability of amikacin in infusional solutions].

  Naumann G, Hussein C, Hussein K, Straube E. Naumann G, et al. Z Gesamte Hyg. 1983 Jun;29(6):329-31. Z Gesamte Hyg. 1983. PMID: 6613186 German. No abstract available.
• Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.

  Chiappetta DA, Sosnik A. Chiappetta DA, et al. Eur J Pharm Biopharm. 2007 Jun;66(3):303-17. doi: 10.1016/j.ejpb.2007.03.022. Epub 2007 Mar 31. Eur J Pharm Biopharm. 2007. PMID: 17481869 Review.